Free press releases distribution network?

Agency / Source: Foamix Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Foamix to Present at the UBS 2010 Global Specialty Pharmaceuticals Conference - The Company will discuss its strategic partnerships and innovative in-house pipeline, including first-in-class Topical Minocycline
Foamix to Present at the UBS 2010 Global Specialty Pharmaceuticals Conference

 

PRZOOM - /newswire/ - Rehovot, Israel, 2010/06/02 - The Company will discuss its strategic partnerships and innovative in-house pipeline, including first-in-class Topical Minocycline.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Foamix Ltd., will present at the UBS 2010 Global Specialty Pharmaceuticals Conference, which will be held from June 2-3 in London, UK.

Dov Tamarkin, Ph.D., Foamix's CEO, will speak on Thursday June 3, 2010 at 9:30 pm London time. He will provide an overview of the company, its technologies and strategic partnerships with pharmaceutical companies. He will further provide an update on Foamix’s innovative drug development pipeline, which includes the first-in-class Topical Minocycline, as well as other proprietary products. Foamix’s Topical Minocycline is currently in Phase II clinical trials in a number of dermatological conditions, with a projected launch in 2013-14.
The Company’s Topical Minocycline will also be developed for a number of ophthalmic and women’s health applications, through partnerships with leading companies in these fields.

About UBS
Headquartered in Zurich and Basel, Switzerland, UBS is a client-focused financial services firm that offers a combination of wealth management, asset management and investment banking services on a global and regional basis. By delivering a full range of advice, products and services to its private, corporate and institutional clients, UBS aims to generate sustainable earnings, create value for its shareholders, and become the choice of clients worldwide.
The UBS 2010 Global Specialty Pharmaceuticals Conference will take place from Wednesday, 2 - Thursday, 3 June 2010 at the UBS Offices, 1 Finsbury Avenue, London EC2M 2PP.

About Foamix Ltd
Headquartered in Rehovot, Israel, Foamix Ltd. (foamix.co.il) is a clinical-stage, privately held specialty pharmaceutical company, focused on the development of proprietary topical foam and OilGel™ products for prescription, OTC and cosmetic applications. By incorporating drugs in foam and OilGel™, Foamix creates advanced, patent protected products with improved convenience, higher compliance and better efficacy. The company’s development capabilities range from initial development of the formulations to scale-up, GMP manufacturing, preclinical and clinical studies.
Foamix partners with leading pharmaceutical companies, including Galderma, Bayer, Dr. Reddy's and Ferndale Laboratories.
Foamix further has its own in-house pipeline of dermatological and gynecological drugs. The Company’s lead product, Topical Minocycline, is in clinical development for the treatment of rosacea, acne and skin infections; Topical Minocycline has further applications in the fields of ophthalmic therapy and gynecology.

To date, Foamix has twenty three issued patents worldwide covering its foam and OilGel™ technology platforms, including 8 issued patents in the United States. The company has an additional 150 pending patent applications worldwide, of which more than 50 are filed in the U.S.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Foamix Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Foamix to Present at the UBS 2010 Global Specialty Pharmaceuticals Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Dov Tamarkin - Foamix.co.il 
+972 8 9316233 dov[.]foamix.co.il
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Foamix Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Foamix Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  SKS Media | SKS Associates Ltd

Visit  NAKIVO, Inc.

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today